Kalyan Ghatak
Concepts (87)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Erectile Dysfunction | 12 | 2021 | 85 | 2.000 |
Why?
| Penis | 12 | 2021 | 79 | 1.690 |
Why?
| Penile Erection | 10 | 2021 | 22 | 1.550 |
Why?
| Intercellular Signaling Peptides and Proteins | 2 | 2018 | 104 | 0.740 |
Why?
| Diabetes Mellitus, Experimental | 7 | 2021 | 129 | 0.730 |
Why?
| Nerve Regeneration | 3 | 2020 | 21 | 0.700 |
Why?
| Pericytes | 5 | 2021 | 13 | 0.530 |
Why?
| Endothelial Cells | 7 | 2021 | 269 | 0.460 |
Why?
| Neovascularization, Physiologic | 4 | 2021 | 68 | 0.390 |
Why?
| Mice, Inbred C57BL | 11 | 2021 | 1816 | 0.380 |
Why?
| Nerve Growth Factor | 2 | 2020 | 12 | 0.350 |
Why?
| Antibodies, Neutralizing | 2 | 2020 | 64 | 0.340 |
Why?
| Mice | 11 | 2021 | 5739 | 0.270 |
Why?
| Phosphodiesterase 5 Inhibitors | 3 | 2019 | 7 | 0.230 |
Why?
| Endothelium | 3 | 2019 | 39 | 0.230 |
Why?
| Animals | 13 | 2021 | 13187 | 0.220 |
Why?
| Coculture Techniques | 3 | 2018 | 146 | 0.220 |
Why?
| Angiopoietin-1 | 2 | 2021 | 16 | 0.200 |
Why?
| Prostatectomy | 2 | 2020 | 81 | 0.190 |
Why?
| Disease Models, Animal | 4 | 2020 | 1455 | 0.190 |
Why?
| Blood Vessels | 2 | 2019 | 72 | 0.190 |
Why?
| Protein Precursors | 1 | 2020 | 43 | 0.180 |
Why?
| Gene Expression | 2 | 2020 | 609 | 0.180 |
Why?
| Peripheral Nerve Injuries | 1 | 2020 | 24 | 0.180 |
Why?
| Embryonic Stem Cells | 1 | 2019 | 15 | 0.180 |
Why?
| Hepatocyte Growth Factor | 2 | 2016 | 9 | 0.170 |
Why?
| Diabetes Complications | 1 | 2020 | 118 | 0.170 |
Why?
| Cell Cycle Proteins | 1 | 2021 | 166 | 0.170 |
Why?
| Mice, Transgenic | 2 | 2018 | 555 | 0.170 |
Why?
| Nanostructures | 1 | 2019 | 47 | 0.170 |
Why?
| Adaptor Proteins, Signal Transducing | 1 | 2020 | 197 | 0.170 |
Why?
| Male | 13 | 2021 | 25241 | 0.160 |
Why?
| Receptor, TIE-2 | 1 | 2018 | 16 | 0.160 |
Why?
| Ganglion Cysts | 1 | 2017 | 2 | 0.150 |
Why?
| Trauma, Nervous System | 1 | 2017 | 5 | 0.150 |
Why?
| Neurites | 1 | 2017 | 13 | 0.150 |
Why?
| Nerve Growth Factors | 1 | 2017 | 27 | 0.150 |
Why?
| Endothelium, Vascular | 1 | 2018 | 252 | 0.140 |
Why?
| Aging | 1 | 2020 | 687 | 0.130 |
Why?
| Diabetes Mellitus, Type 1 | 1 | 2018 | 198 | 0.130 |
Why?
| Electroporation | 1 | 2015 | 17 | 0.130 |
Why?
| Genetic Therapy | 1 | 2015 | 114 | 0.120 |
Why?
| Nitric Oxide Synthase Type III | 2 | 2021 | 78 | 0.080 |
Why?
| Multiple Myeloma | 1 | 2023 | 2929 | 0.080 |
Why?
| Regeneration | 2 | 2020 | 72 | 0.080 |
Why?
| Vascular Endothelial Growth Factor A | 2 | 2021 | 201 | 0.080 |
Why?
| Phosphorylation | 2 | 2021 | 535 | 0.070 |
Why?
| Gene Expression Profiling | 2 | 2023 | 1032 | 0.070 |
Why?
| Cell Proliferation | 2 | 2023 | 1007 | 0.070 |
Why?
| Cells, Cultured | 2 | 2020 | 1573 | 0.060 |
Why?
| Tight Junction Proteins | 1 | 2021 | 7 | 0.050 |
Why?
| Angiogenic Proteins | 1 | 2020 | 6 | 0.050 |
Why?
| Receptors, Nerve Growth Factor | 1 | 2020 | 6 | 0.050 |
Why?
| Primary Cell Culture | 1 | 2020 | 61 | 0.050 |
Why?
| Sequence Analysis, RNA | 1 | 2020 | 91 | 0.040 |
Why?
| Drug Evaluation, Preclinical | 1 | 2020 | 144 | 0.040 |
Why?
| Streptozocin | 1 | 2019 | 23 | 0.040 |
Why?
| Transcription Factors | 1 | 2023 | 561 | 0.040 |
Why?
| Cell Movement | 1 | 2020 | 247 | 0.040 |
Why?
| Down-Regulation | 1 | 2021 | 348 | 0.040 |
Why?
| Neoplasm Recurrence, Local | 1 | 2023 | 614 | 0.040 |
Why?
| Up-Regulation | 1 | 2021 | 452 | 0.040 |
Why?
| Humans | 6 | 2023 | 49974 | 0.040 |
Why?
| Glucose | 1 | 2020 | 344 | 0.040 |
Why?
| Crosses, Genetic | 1 | 2018 | 31 | 0.040 |
Why?
| Diabetic Angiopathies | 1 | 2018 | 18 | 0.040 |
Why?
| Diabetic Nephropathies | 1 | 2018 | 61 | 0.040 |
Why?
| Wnt Signaling Pathway | 1 | 2018 | 92 | 0.040 |
Why?
| Injections, Intralesional | 1 | 2016 | 31 | 0.040 |
Why?
| Matrix Metalloproteinase 2 | 1 | 2016 | 57 | 0.030 |
Why?
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2015 | 20 | 0.030 |
Why?
| Permeability | 1 | 2015 | 68 | 0.030 |
Why?
| Recombinant Proteins | 1 | 2016 | 486 | 0.030 |
Why?
| Lipoproteins, LDL | 1 | 2016 | 170 | 0.030 |
Why?
| Gene Transfer Techniques | 1 | 2015 | 37 | 0.030 |
Why?
| Luciferases | 1 | 2015 | 50 | 0.030 |
Why?
| Cell Separation | 1 | 2015 | 89 | 0.030 |
Why?
| Genes, Reporter | 1 | 2015 | 89 | 0.030 |
Why?
| Transfection | 1 | 2015 | 354 | 0.030 |
Why?
| Cell Line, Tumor | 1 | 2018 | 1403 | 0.030 |
Why?
| Apoptosis | 1 | 2019 | 1101 | 0.030 |
Why?
| Rats, Sprague-Dawley | 1 | 2016 | 1597 | 0.030 |
Why?
| Diabetes Mellitus, Type 2 | 1 | 2018 | 477 | 0.030 |
Why?
| Antibodies, Monoclonal | 1 | 2015 | 459 | 0.020 |
Why?
| Signal Transduction | 1 | 2016 | 1618 | 0.020 |
Why?
| Young Adult | 1 | 2018 | 3958 | 0.020 |
Why?
| Adult | 1 | 2018 | 13236 | 0.010 |
Why?
|
|
Ghatak's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|